摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-n-butyl-N-(2-diethylaminoethyl)amine | 50342-04-6

中文名称
——
中文别名
——
英文名称
N-n-butyl-N-(2-diethylaminoethyl)amine
英文别名
N'-butyl-N,N-diethyl-ethane-1,2-diamine;N,N-diethyl-N'-butyl-ethylenediamine;N,N-Diaethyl-N'-butyl-aethylendiamin;N-butyl-N',N'-diethylethane-1,2-diamine
N-n-butyl-N-(2-diethylaminoethyl)amine化学式
CAS
50342-04-6
化学式
C10H24N2
mdl
MFCD11144302
分子量
172.314
InChiKey
LQVFVMJVCVOTJT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    12
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    15.3
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis and Antitumor Activity of 20(S)-Camptothecin Derivatives: Carbamate-Linked, Water-Soluble Derivatives of 7-Ethyl-10-hydroxycamptothecin.
    作者:Seigo SAWADA、Satoru OKAJIMA、Ritsuo AIYAMA、Ken-ichiro NOKATA、Tomio FURUTA、Teruo YOKOKURA、Eiichi SUGINO、Kentaro YAMAGUCHI、Tadashi MIYASAKA
    DOI:10.1248/cpb.39.1446
    日期:——
    Nevel 36 derivatives (6), bonding the phenolic hydroxyl group of 7-ethyl-10-hydroxycamptothecin (4) with diamines through a monocarbamate linkage, were synthesized and their antitumor activity was evaluated in vivo. The derivatives were soluble in water as their HC1 salts wiht the E lactone ring intact and exhibited significant antitumor activity. One of the derivatives, 6-27 showed excellent activity against L1210 leukemia and other murine tumors.The structure of its hydrochloride trihydrate (CPT-11) was determined by spectroscopic and crystallographic methods.
    Nevel 36衍生物(6个)通过单氨基甲酸酯连接,将7-乙基-10-羟基喜树碱(4)的酚羟基与二胺结合,经过合成并在体内评估了它们的抗肿瘤活性。这些衍生物作为盐酸盐在水中有较好的溶解度,且其E内酯环保持完整,并表现出显著的抗肿瘤活性。其中一种衍生物6-27对L1210白血病和其他小鼠肿瘤显示出极佳的活性。其三水合盐酸盐(CPT-11)的结构通过光谱学和结晶学方法得以确定。
  • LYSINE SPECIFIC DEMETHYLASE-1 INHIBITORS AND THEIR USE
    申请人:Ortega Muñoz Alberto
    公开号:US20120283266A1
    公开(公告)日:2012-11-08
    The invention relates to a compound of Formula (I): (A′) x -(A)-(B)-(Z)-(L)-(D), wherein: (A) is heteroaryl or aryl; each (A′), if present, is independently chosen from aryl, arylalkoxy, arylalkyl, heterocyclyl, aryloxy, halo, alkoxy, haloalkyl, cycloalkyl, haloalkoxy, and cyano, wherein each (A′) is substituted with 0, 1, 2, or 3 substituents independently chosen from halo, haloalkyl, aryl, arylalkoxy, alkyl, alkoxy, cyano, sulfonyl, amido, and sulfinyl; X is 0, 1, 2, or 3; (B) is a cyclopropyl ring, wherein (A) and (Z) are covalently bonded to different carbon atoms of (B); (Z) is —NH—; (L) is chosen from —CH 2 CH 2 —, —CH 2 CH 2 CH 2 —, and —CH 2 CH 2 CH 2 CH 2 —; and (D) is chosen from —N(—R1)—R2, —O—R3, and —S—R3, wherein: R1 and R2 are mutually linked to form a heterocyclic ring together with the nitrogen atom that R1 and R2 are attached to, wherein said heterocyclic ring has 0, 1, 2, or 3 substituents independently chosen from —NH 2 , —NH(C 1 -C 6 alkyl), —N(C 1 -C 6 alkyl)(C 1 -C 6 alkyl), alkyl, halo, cyano, alkoxy, haloalkyl, and haloalkoxy, or R1 and R2 are independently chosen from —H, alkyl, cycloalkyl, haloalkyl, and heterocyclyl, wherein the sum of substituents on R1 and R2 together is 0, 1, 2, or 3, and the substituents are independently chosen from —NH 2 , —NH(C 1 -C 6 alkyl), —N(C 1 -C 6 alkyl)(C 1 -C 6 alkyl), and fluoro; and R3 is chosen from —H, alkyl, cycloalkyl, haloalkyl, and heterocyclyl, wherein R3 has 0, 1, 2, or 3 substituents independently chosen from —NH 2 , —NH(C 1 -C 6 alkyl), —N(C 1 -C 6 alkyl)(C 1 -C 6 alkyl), and fluoro; or an enantiomer, diastereomer, or mixture thereof, or a pharmaceutically acceptable salt or solvate thereof. The compounds of the invention show inhibitory LSD1 activity, which makes them useful in the treatment or prevention of diseases such as cancer.
    本发明涉及一种化合物,其化学式为(I):(A′)x-(A)-(B)-(Z)-(L)-(D),其中:(A)为杂环芳基或芳基;每个(A′),如果存在,则独立选择自芳基、芳基烷氧基、芳基烷基、杂环芳基、芳基氧基、卤、烷氧基、卤代烷基、环烷基、卤代烷氧基和氰,其中每个(A′)均被取代为0、1、2或3个取代基,所述取代基独立选择自卤、卤代烷基、芳基、芳基烷氧基、烷基、烷氧基、氰、磺酰基、酰胺和亚磺酰基;X为0、1、2或3;(B)为环丙基环,其中(A)和(Z)与(B)的不同碳原子共价键合;(Z)为—NH—;(L)选择自—CH2CH2—、—CH2CH2CH2—和—CH2CH2CH2CH2—;(D)选择自—N(—R1)—R2、—O—R3和—S—R3,其中:R1和R2与氮原子一起互相连接形成一个杂环环,所述杂环环具有0、1、2或3个取代基,所述取代基独立选择自—NH2、—NH(C1-C6烷基)、—N(C1-C6烷基)(C1-C6烷基)、烷基、卤、氰、烷氧基、卤代烷基和卤代烷氧基,或R1和R2独立选择自—H、烷基、环烷基、卤代烷基和杂环芳基,其中R1和R2的取代基总和为0、1、2或3,所述取代基独立选择自—NH2、—NH(C1-C6烷基)、—N(C1-C6烷基)(C1-C6烷基)和氟;R3选择自—H、烷基、环烷基、卤代烷基和杂环芳基,其中R3具有0、1、2或3个取代基,所述取代基独立选择自—NH2、—NH(C1-C6烷基)、—N(C1-C6烷基)(C1-C6烷基)和氟;或其对映体、顺反异构体或混合物,或其药学上可接受的盐或溶剂。本发明的化合物显示出抑制LSD1活性,因此它们在治疗或预防癌症等疾病方面非常有用。
  • Chlorine-resistant polyethylene compound and articles made therefrom
    申请人:Fina Technology, Inc.
    公开号:US10584823B2
    公开(公告)日:2020-03-10
    A method includes transporting water containing chlorine dioxide, chlorine, chloramines, or hypochlorites through a pipe. The method includes forming a polyethylene resin using a catalyst, mixing the polyethylene resin with an antioxidant, wherein the antioxidant is a thioester, a hindered amine light stabilizer or 1,3,5-trimethyl-2,4,6-tris (3,5-di-tert-butyl-4-hydroxybenzyl) benzene to form a resin/antioxidant mixture, extruding pipe from the resin/antioxidant mixture, and flowing water containing chlorine dioxide, chlorine, chloramines, or hypochlorites through the pipe. An extruded article is adapted for use in containment and/or transport of water that contains chlorine dioxide, chlorine, chloramines, or hypochlorites. The extruded article includes a polyethylene resin and an antioxidant. The antioxidant is a thioester, a hindered amine light stabilizer or 1,3,5-trimethyl-2,4,6-tris (3,5-di-tert-butyl-4-hydroxybenzyl) benzene.
    一种方法包括通过管道输送含有二氧化氯、氯、氯胺或次氯酸盐的水。该方法包括使用催化剂形成聚乙烯树脂,将聚乙烯树脂与抗氧化剂混合,其中抗氧化剂为硫酯、受阻胺光稳定剂或 1,3,5-三甲基-2,4,6-三(3、5-二叔丁基-4-羟基苄基)苯形成树脂/抗氧化剂混合物,用树脂/抗氧化剂混合物挤出管材,并使含有二氧化氯、氯、氯胺或次氯酸盐的水流过管材。挤压制品适用于封闭和/或运输含有二氧化氯、氯、氯胺或次氯酸盐的水。挤压制品包括聚乙烯树脂和抗氧化剂。抗氧化剂是硫酯、受阻胺光稳定剂或 1,3,5-三甲基-2,4,6-三(3,5-二叔丁基-4-羟基苄基)苯。
  • Wadia et al., Journal Of Scientific and Industrial Research, 1958, vol. 17B, p. 11,20
    作者:Wadia et al.
    DOI:——
    日期:——
  • Thuillier,G. et al., Bulletin de la Societe Chimique de France, 1963, p. 1087 - 1090
    作者:Thuillier,G. et al.
    DOI:——
    日期:——
查看更多

同类化合物

(N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷 顺,顺-丙二腈 非那唑啉 靛酚钠盐 靛酚 霜霉威盐酸盐 霜脲氰